Search

Your search keyword '"Rosenstein, Barry"' showing total 829 results

Search Constraints

Start Over You searched for: Author "Rosenstein, Barry" Remove constraint Author: "Rosenstein, Barry"
829 results on '"Rosenstein, Barry"'

Search Results

1. Professional-patient discrepancies in assessing lung cancer radiotherapy symptoms: An international multicentre study

2. Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score

3. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants

4. Optimising inter-patient image registration for image-based data mining in breast radiotherapy

6. Contributors

7. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis

8. Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer.

9. Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy

10. Polygenic hazard score is associated with prostate cancer in multi-ethnic populations.

11. Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer

13. Genomics models in radiotherapy: from mechanistic to machine learning

14. Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study

15. The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study

16. Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort

18. Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort

20. Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

21. Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

22. Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry.

23. Performance/outcomes data and physician process challenges for practical big data efforts in radiation oncology

24. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

26. Sexual health outcomes in sexual minority vs. heterosexual men after prostate radiotherapy.

27. A data science approach for early-stage prediction of Patient's susceptibility to acute side effects of advanced radiotherapy

28. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

29. Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

32. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis

33. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

34. Observational and genetic associations between cardiorespiratory fitness and cancer : a UK Biobank and international consortia study

35. Observational and genetic associations between cardiorespiratory fitness and cancer:a UK Biobank and international consortia study

36. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

37. Optimising Inter-Patient Image Registration for Image-Based Data Mining in Breast Radiotherapy

38. Genetic Variants Predict Optimal Timing of Radiotherapy to Reduce Side-effects in Breast Cancer Patients

41. 1461: Prostate cancer patients with lower muscle mass have increased late toxicities post-radiotherapy.

42. 1378: Genetically-based analysis of dose surface maps for assessing toxicity post-RT: an innovative method

43. 1242: Sensitivity of dose-response mapping model parameters at the bladder and rectum in prostate cancer

44. 2937: Dose deposition in sub-regions of breast relates to acute and persistent pain after radiotherapy

45. Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.

46. Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data: dosimetry, acute and two years physician and patient-reported outcomes

48. Dose to the Contralateral Breast From Radiotherapy and Risk of Second Primary Breast Cancer in the WECARE Study

Catalog

Books, media, physical & digital resources